IRCT2015012520781N1已完成未知
Evaluation of the effect of silimarin in children with nonalcoholic fatty liver disease
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 16 years（—）
- 性别
- All
入选标准
- •Obese children with non-alcoholic fatty liver manifestations in ultrasonography.
- •Exclusion criteria : Use of ethanol; use of hepatotoxic drugs; hepatitis B and C; autoimmune hepatitis; Wilson disease; Hemochromatosis; alpha-1 antitrypsin; severe coronary disease; severe lung disease; liver cirrhosis
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
已完成
不适用
Effect of silymarin in prevention of adverse effects of anti tuberculosis drugsDrug induced hepatitis by anti tuberculosis.Antimycobacterial drugsIRCT138903294209N1ational Institute of tuberculosis and lung disease60
招募中
3 期
Evaluating the effect of silymarin oral form on the control of liver toxicity caused by adriamycin and cyclophosphamide drugs in patients with non metastatic breast cancerIRCT2017091136125N1Vice chancellor for research, Mashhad University of Medical Sciences40
已完成
2 期
To evaluate the effectiveness of Silymarin (Livergol) on IL-6 levels and size of endometrioma lesionsIRCT20150905023897N5Vice chancellor for research Tarbiat Modares University60